The fight against cancer is constant,
and early detection is essential. Traditional biopsy procedures are
effective for early detection, but can be invasive and carry risks.
Fortunately, the liquid biopsy offers a potentially simpler and less
intrusive approach to its counterpart.
Voler Systems, a well-known company specializing in complex medical device design,
collaborated with Guangzhou EZLife BioSci Tech Co. Ltd. on a ground
breaking project. This project involved developing a liquid biopsy
platform for early lung cancer detection. The innovative platform uses a
medical instrument developed to analyze minuscule electrical currents
within a blood sample.
The Challenge - Taking Accurate Measurements in a Noisy Environment
The challenge facing this China-based company was the complexity of the instrument. It requires extreme precision to accurately measure electrical currents (from 10 picoamps to 50 microamps) within a blood sample. In addition, the external noise stood out as a significant threat as it could disrupt the delicate measurements.
Voler Systems' Expertise - Developing a Precise Solution
Voler Systems, known for its skill in designing intricate medical devices and ability to collaborate remotely, used a wealth of experience and advanced analog design skills to address these challenges.
Here's how Voler Systems handled the issues:
- Custom
Circuit Design - Without a readily available off-the-shelf solution,
Voler Systems developed a customized circuit design specifically
tailored to the project's needs.
- Minimizing Noise - Voler Systems implemented low-noise design principles to protect the delicate measurements from external interference.
- Self-Calibration - The design incorporated self-calibration functionality to provide consistent accuracy over time.
- Project Management Expertise - Voler Systems implemented a meticulous project management strategy to ensure the project stayed on track and met the client's objectives.
The Result - A Successful Collaboration with Real-World Impact
With efficient collaboration and exceptional engineering capabilities, Voler Systems was able to provide the client with a remarkable solution. The resulting circuit board features:
- Low Leakage Currents -This reduces interference and offers accurate readings.
- Multi-Channel Design – The circuit board has 96 channels for simultaneous analysis of multiple samples.
- Enhanced Shielding - Superior shielding techniques to block external noise effectively.
- Balanced Design - Balanced all circuit and software interactions to provide precise measurements.
This project met the company’s goals and paved the way for a potentially life-changing medical advancement. Successfully using the first circuit boards in a lab setting showcases the significant step forward in early lung cancer detection with a noninvasive liquid biopsy approach.
Looking to the Future with Voler Systems
The fight against cancer continues, and Voler Systems is ready to collaborate with companies pushing the boundaries of medical technology. If you're developing a ground-breaking medical device and require a medical device design consultant, consider partnering with Voler Systems. Contact us today and let us turn your vision for a healthier future into reality.
Comments
Post a Comment